TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Increase in reaction times (RTs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MADRS Thai scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total power reflecting autonomic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: successful pregnancy outcomes
Endpoint domain: Mortality/survival
Primary endpoint: infant outcomes
Endpoint domain: Mortality/survival
Primary endpoint: CPM function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Craving reduction during opioid withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔCA125
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of smell
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: False positive rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Glycemic control (HbA1c and fasting plasma glucose)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Functional Assessment of Chronic Illness Therapy‐Fatigue score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: six‐minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of newborns with a birth weight <2.4 kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Head circumference of newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention decay rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve (AUC(12))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy for exercise
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-reported levels of exercise
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Function (BASFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patients' symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 50% or greater reduction in pad weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Negative cough stress test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Improvement in patient reported measures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to exercise
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PFM contractions performed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endoscopic cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall therapeutic response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of easy transfers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean increase in 25(OH)D2 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Onset time of pruritus
Endpoint domain: Adverse events/effects
Primary endpoint: Physicians' evaluation time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Psychosocial functioning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Intensity of opiate withdrawal syndrome (OWS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alkaline phosphatase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Joint maximal range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety and efficacy of investigational therapeutics in Ebola patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term health effects following Shiga Toxin‐Producing Escherichia coli outbreak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: epidemiological information to mitigate impact of EIDs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Occurrence of CI-AKI
Endpoint domain: Adverse events/effects
Primary endpoint: risk of wheeze
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: MCP-1 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cumulative percent ventricular pacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Length of abstinence
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: 12-month MACE rates
Endpoint domain: Mortality/survival
Primary endpoint: mean in-segment late lumen loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean in-stent late lumen loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetus mean expulsion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Eyelid swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Complete response of antiemesis in the first 24-hour period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete response for delayed emesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone density preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of experimental gingivitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma content of SP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma content of CGRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regular withdrawal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: daily walking reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SRS total raw score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse event related monetary wastage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Deviation in flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of atrial fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: successful cleansing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Understanding of acupuncture for insomnia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: sensitivity for naming errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: specificity for naming errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in core temperature (CT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysphagia score postoperatively
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Wallstent patency at 1 and 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate complications
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality rate after 1 year
Endpoint domain: Mortality/survival
Primary endpoint: SDR (Standardized Deviation Ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skull volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini-BESTest improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TUG Dual Task score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QTcI duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: severe agitation incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severe pain incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of severe coughs per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiologic eradication rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cord arterial pH values < 7.20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased intensity of acute tonsillitis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alleviation of local symptoms and general condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase of the number of treatment responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative delirium (POD)
Endpoint domain: Adverse events/effects
Primary endpoint: Onset of postoperative delirium (POD)
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of postoperative delirium (POD)
Endpoint domain: Adverse events/effects
Primary endpoint: neurodevelopmental/neurosensory impairment by 5 years of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tolerability of sodium picosulphate
Endpoint domain: Adverse events/effects
Primary endpoint: cold-induced wheal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTT and CSTT values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACU lesion severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time taken for fever to subside
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haemodynamic support needed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Glasgow coma scale score normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Exclusive breastfeeding rates at 6 months postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial breastfeeding rates at 6 months postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 3-4 hematological toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Movement amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of urinary 8‐OHdG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CIS fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: CDC symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SIP8
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Weekly rHuEpo requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transferrin saturation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Epidural use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Soft tissue complications
Endpoint domain: Adverse events/effects
Primary endpoint: Horizontal bone thickness at implant shoulder level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Vertical bone defect component reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: periprocedural pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: major motion artifacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Framingham 10-year risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency and intensity of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative trismus
Endpoint domain: Adverse events/effects
Primary endpoint: Antibody titers post-vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to successful completion of pelvic ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: First-attempt success rate for transabdominal pelvic ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Arthrogenous Muscle Inhibition (AMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tamoxifen-induced hot flushes
Endpoint domain: Adverse events/effects
Primary endpoint: tolerability of pimecrolimus cream
Endpoint domain: Adverse events/effects
Primary endpoint: improvement in treatment parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: ankle score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severe treatment-related morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: fatal event
Endpoint domain: Mortality/survival
Primary endpoint: Mean decrease in FBG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving target HbA1c level <7.0%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSQI global sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Early recurrence (ER) of atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Equol excretion status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma hormone concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leptin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in serum 25‐OH‐D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nighttime melatonin secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vegetable consumption increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fruit intake maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: sensitivity for inferior frontal and posterior temporal activations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Deltab* (yellowness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DeltaL* (brightness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure and improvement measured by pad test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in eGFR levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Primary end-point event occurrence
Endpoint domain: Mortality/survival
Primary endpoint: N-terminal pro-brain natriuretic peptide levels reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful balloon aortic valvuloplasty (BAV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Duration of adenosine-induced atrioventricular (AV) block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of bradycardia
Endpoint domain: Adverse events/effects
Primary endpoint: Nasal Symptoms Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (nausea, vomiting, diarrhea)
Endpoint domain: Adverse events/effects
Primary endpoint: Preference for patient-centred consulting style
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean penetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum dye penetration score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ad48 neutralizing antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: EnvA-specific enzyme-linked immunosorbent assay titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: EnvA-specific enzyme-linked immunospot assay responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Performance on individual goals
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Starting and consummating time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persisting time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade I-II neuro-sensory toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Grade I-II granulocytopenia
Endpoint domain: Adverse events/effects
Primary endpoint: Mean area under the serum concentration time curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal halflives
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak serum concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients achieving target HR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient satisfaction with PCRA
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: myocardial function depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: fALFF in the cerebellar vermis and right fusiform gyrus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: vermal FC with subcortical and cortical targets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Symptomatic improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wee-FIM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal Peak Inspiratory Flow (NPIF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: expectancies of getting in trouble due to alcohol consumption
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Insulin resistance (HOMA-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Normalized spectral power of serum insulin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: perceived quality of pregnancy care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: involvement in decision-making
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: spiritual wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attendance rate at group exercise sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement levels of residents in exercise groups
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: H-reflex amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: H-reflex threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pancreaticojejunostomy leakage
Endpoint domain: Adverse events/effects
Primary endpoint: Ideal intubation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: laxative free remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission or improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CBCL school scale scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Swimming ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-treatment drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short-term infection
Endpoint domain: Adverse events/effects
Primary endpoint: long-term infection
Endpoint domain: Adverse events/effects
Primary endpoint: Negative subscale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative 3-year cumulative survival rates
Endpoint domain: Mortality/survival
Primary endpoint: memory outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motivation for lifestyle change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean nitrite concentration in supernatants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DOO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Viscosity (PV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes